Aryzta reported higher first-quarter revenue driven by growth in the Europe segment and said it was on track to meet its low to mid-single digit organic growth target for this year.

Quest Diagnostics (DGX) reports 12% Q1 2025 revenue growth, driven by acquisitions, partnerships, and advanced diagnostics.

Cadre Holdings posted strong Q4 results, but slowing growth, valuation concerns, and tariff risks cloud the outlook. Learn ...

The advertising and marketing-services group confirmed its outlook for the year after first-quarter organic growth beat ...

Xvivo Perfusion AB (XVIPF) reports strong financial performance with significant growth in thoracic sales and strategic ...

Q1 2025 Management View CEO Henry Fernandez highlighted MSCI's financial performance with 10% organic revenue growth, 11% adjusted EBITDA growth, and a 14% increase in adjusted EPS. The company ...

The Dutch brewer backed its full-year guidance after quarterly performance beat market expectations, but warned that the ...

Omnicom, working toward finalising the acquisition of competitor IPG later this year, is developing plans for integrating its ...

S4 Capital’s business is smaller and less diverse than that of larger advertising holding companies, making it more susceptible to economic downturns and higher volatility in its operating and credit ...

Rentokil's North American pest control business, which has struggled to integrate Terminix, saw organic growth of 0.7%, within the range of analyst expectations. While not a turnaround ...

The IT major is expected to post a 5.4 per cent decline in net profit for the fourth quarter sequentially to ₹4,341.8 crore ...